Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Wang, Shengjun (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S359000
Reexamination Certificate
active
08003674
ABSTRACT:
Disclosed herein are compounds, compositions and methods for treating or ameliorating flavivirus infections. This is particularly important because the present disclosure provides methods for treating flavivirus infections for which there is no effective vaccine.
REFERENCES:
patent: 6258831 (2001-07-01), Camden
patent: 2006/0025416 (2006-02-01), Phadke et al.
patent: WO 2006/060774 (2006-06-01), None
Paula “New Drug target for hepatitis C and other Flaviviridae viruses,” Infectious Disorders-Drug Targets, 2009, vol. 9, pp. 133-147.
Buckwood et al. “Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents,” Antiviral Research, 2003, vol. 60 pp. 1-15.
Linden and Goerdeler, “Reaktion von Iminodithiazolen mit Sulfenen zu S-Fliedrigen Sultamen,”Tetrahedron Letters20:1729-1732, 1977.
Barklis et al., “Sultam Thiourea Inhibition of West Nile Virus,”Antimicrob. Agents Chemother. 51:2642-2645, 2007.
Klarquist & Sparkman, LLP
Oregon Health & Science University
Wang Shengjun
LandOfFree
Flavivirus inhibition by sultams and related compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flavivirus inhibition by sultams and related compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flavivirus inhibition by sultams and related compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2697488